Copy of The Global Medicinal Market

The Global Medicinal Market

The tipping point has been reached. The medicinal benefits cannot be overlooked anymore. This is having a significant impact on diseases such as MS and Epilepsy, and is now the hottest topic in the ability of pain prevention – a $650 billion dollar market.  

The industry is seeing unprecedented growth due to decriminalisation for medicinal purposes on a global scale. Already, it has been legalised for medicinal use in various states in the USA as well as other global countries such as Canada, Australia and Germany.

 

 

 The industry is expected to grow at a compound rate of 35% year on year.
The industry is expected to grow at a compound rate of 35% year on year.

 

As the medicinal benefits start to gain mainstream acceptance within the medical profession, so the acceptance of the plant itself gains momentum. So much so, that on the 1st of January 2018, California legalised its use for adult use & Canada will lift prohibition in late August.

 

There are currently more than 600 publicly traded companies in this industry. We focus purely on this market helping you – our community – to identify the right stocks to add to your investment portfolio at the right time and for the right price on both local and international exchanges.